These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6394211)

  • 1. Riboflavin use as a drug marker in Veterans Administration cooperative studies.
    Young LM; Haakenson CM; Lee KK; van Eeckhout JP
    Control Clin Trials; 1984 Dec; 5(4 Suppl):497-504. PubMed ID: 6394211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veterans Administration cooperative study of disulfiram in the treatment of alcoholism: study design and methodological considerations.
    Fuller RK; Williford WO; Lee KK; Derman R
    Control Clin Trials; 1984 Sep; 5(3):263-73. PubMed ID: 6386330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance with disulfiram treatment of alcoholism.
    Fuller R; Roth H; Long S
    J Chronic Dis; 1983; 36(2):161-70. PubMed ID: 6337171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfiram treatment of alcoholism. A Veterans Administration cooperative study.
    Fuller RK; Branchey L; Brightwell DR; Derman RM; Emrick CD; Iber FL; James KE; Lacoursiere RB; Lee KK; Lowenstam I
    JAMA; 1986 Sep; 256(11):1449-55. PubMed ID: 3528541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence.
    McRae-Clark AL; Baker NL; Sonne SC; DeVane CL; Wagner A; Norton J
    J Subst Abuse Treat; 2015 Oct; 57():70-4. PubMed ID: 26028133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to court-ordered disulfiram at fifteen months: a naturalistic study.
    Martin BK; Clapp L; Alfers J; Beresford TP
    J Subst Abuse Treat; 2004 Apr; 26(3):233-6. PubMed ID: 15063918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riboflavin as an independent and accurate biomarker for adherence in a randomized double-blind and placebo-controlled clinical trial.
    Ramanujam VS; Nayeem F; Anderson KE; Kuo YF; Chen NW; Ju H; Lu LW
    Biomarkers; 2017 Sep; 22(6):508-516. PubMed ID: 27918196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone.
    Kalichman SC; Amaral CM; Stearns H; White D; Flanagan J; Pope H; Cherry C; Cain D; Eaton L; Kalichman MO
    J Gen Intern Med; 2007 Jul; 22(7):1003-6. PubMed ID: 17390095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity.
    Kalichman SC; Amaral CM; Cherry C; Flanagan J; Pope H; Eaton L; Kalichman MO; Cain D; Detorio M; Caliendo A; Schinazi RF
    HIV Clin Trials; 2008; 9(5):298-308. PubMed ID: 18977718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a urinary riboflavin adherence marker for a wheat bran fiber community intervention trial.
    Switzer BR; Stark AH; Atwood JR; Ritenbaugh C; Travis RG; Wu HM
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):439-42. PubMed ID: 9184778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues in medication adherence assessment in clinical trials of the National Heart, Lung, and Blood Institute.
    Mattson ME; Friedman LM
    Control Clin Trials; 1984 Dec; 5(4 Suppl):488-96. PubMed ID: 6518777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts.
    Matsuyama JR; Mason BJ; Jue SG
    Ann Pharmacother; 1993; 27(7-8):851-5. PubMed ID: 8364262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pill count measures of compliance in a drug trial: variability and suitability.
    Rudd P; Byyny RL; Zachary V; LoVerde ME; Mitchell WD; Titus C; Marshall G
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):309-12. PubMed ID: 3291897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measures of adherence to oral hypoglycemic agents at the primary care clinic level: the role of risk adjustment.
    Wong ES; Piette JD; Liu CF; Perkins M; Maciejewski ML; Jackson GL; Blough DK; Fihn SD; Au DH; Bryson CL
    Med Care; 2012 Jul; 50(7):591-8. PubMed ID: 22354208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing compliance of drug taking--a simple bed side method.
    Thilothammal N; Krishnamurthy PV; Banu K; Gandhimathy S
    Indian Pediatr; 1995 Mar; 32(3):295-9. PubMed ID: 8613283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer.
    Del Boca FK; Kranzler HR; Brown J; Korner PF
    Alcohol Clin Exp Res; 1996 Nov; 20(8):1412-7. PubMed ID: 8947318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice.
    Farmer KC
    Clin Ther; 1999 Jun; 21(6):1074-90; discussion 1073. PubMed ID: 10440628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance and nutritional status during feasibility study for an intervention trial in China.
    Ershow AG; Zheng SF; Li GY; Li JY; Yang CS; Blot WJ
    J Natl Cancer Inst; 1984 Dec; 73(6):1477-81. PubMed ID: 6595459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfiram (antabuse) contracts in treatment of alcoholism.
    O'Farrell TJ; Allen JP; Litten RZ
    NIDA Res Monogr; 1995; 150():65-91. PubMed ID: 8742773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riboflavin, self-report, and serum norethindrone. Comparison of their use as indicators of adolescent compliance with oral contraceptives.
    Jay S; DuRant RH; Litt IF; Linder CW; Shoffitt T
    Am J Dis Child; 1984 Jan; 138(1):70-3. PubMed ID: 6362397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.